Advertisement
Product Releases
Advertisement

Barrier Gauze Wound Care Dressings

Tue, 07/20/2010 - 7:16am

LISTED UNDER:

Quick-Med Technologies, Inc.’s NIMBUS™ (Novel Intrinsically MicroBonded Utility Substrate) employs a family of advanced antimicrobial polymers that destroy bacteria at the cellular level, thereby eliminating the risk of developing drug resistance.

Quick-Med Technologies, Inc.’s NIMBUS™ (Novel Intrinsically MicroBonded Utility Substrate) employs a family of advanced antimicrobial polymers that destroy bacteria at the cellular level, thereby eliminating the risk of developing drug resistance. Unlike any other microbicide on the market today, NIMBUS works by creating a permanent bond with a multitude of substrates (without leaching) and is less than 10% the cost of similar silver-based antimicrobials.
Studies conducted by the Company, as well as by independent laboratories, demonstrate that NIMBUS is highly effective, including against methicillin-resistant Staphylococcus aureus (“MRSA”) and vancomycin-resistant Enterococcus (“VRE”), two of the most significant antibiotic-resistant organisms responsible for hospital infections.  

For more information, visit www.quickmedtech.com

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading